Veracyte
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $139,071 | $140,636 | $131,872 | $130,164 |
Gross Profit | 100,580 | 104,680 | 91,282 | 89,769 |
EBITDA | 35,404 | 45,932 | 24,155 | 6,739 |
EBIT | 29,974 | 40,634 | 18,889 | 1,250 |
Net Income | 28,707 | 41,149 | 19,137 | -980 |
Net Change In Cash | 139,071 | 140,636 | 131,872 | 130,164 |
Free Cash Flow | 32,253 | 48,270 | 41,965 | 32,319 |
Cash | 263,136 | 362,578 | 315,573 | 219,499 |
Basic Shares | 81,313 | 81,387 | 79,691 | 79,905 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $517,145 | $445,764 | $361,051 | $296,536 |
Gross Profit | 360,045 | 298,145 | 248,148 | 194,954 |
EBITDA | 89,616 | 49,205 | -49,409 | -6,981 |
EBIT | 68,201 | 25,746 | -76,597 | -36,229 |
Net Income | 66,353 | 24,138 | -74,404 | -36,560 |
Net Change In Cash | 517,145 | 445,764 | 361,051 | 296,536 |
Cost of Revenue | -18,358 | |||
Free Cash Flow | 126,630 | 63,809 | 34,261 | -1,014 |
Cash | 362,578 | 239,087 | 216,454 | 154,247 |
Basic Shares | 80,573 | 78,163 | 72,644 | 71,549 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0.52 |
2025-12-31 | $0.53 |
2025-09-30 | $0.51 |
2025-06-30 | $0.44 |